# US 2012/0252820 A1 · Methods of treating fungal infections

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252820 A1
- Document ID: US20120252820A1
- Status: Published application
- Kind: A1
- Application number: 13/513,149
- Filed: 2009-04-22
- Published: 2012-10-04
- Earliest claimed: 2008-04-22
- Assignees: Northeastern University
- Inventors: Kim Lewis; Michael David Lafleur
- Web page: https://patentgrep.com/patent/US20120252820A1

## CPC

- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61K 31/13: Amines {(A61K31/04 takes precedence)}
- A61K 31/4015: having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
- A61K 31/4164: 1,3-Diazoles
- A61K 31/496: Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A61P 1/02: Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A61P 15/00: Drugs for genital or sexual disorders (for disorders of sex hormones A61P5/24); Contraceptives
- A61P 31/10: Antimycotics
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Methods of identifying compounds that potentiate the activity of antifungal agents, potentiators identified by these methods, and methods of using potentiators to treat fungal infections are disclosed.

## Claims

### Claim 1

A method of inhibiting the growth of, or killing, a fungus, the method comprising contacting the fungus with an effective amount of:
(a) an antifungal agent; and
(b) one or more potentiator compounds of Formula I:
or pharmaceutically acceptable salts, hydrates, and solvates thereof,
wherein each R1 is independently —OH, —OC(O)H, —OC(O)alkyl, —NH2, —NH-alkyl, —N(alkyl)2, —NH-aminoacid, —NHC(O)alkyl, —NHC(O)aryl, —NH(S(O)2)alkyl,
wherein the alkyl is optionally substituted, —NH(S(O)2)aryl,
wherein the aryl is optionally substituted, or a five-membered heteroaryl, optionally substituted with alkyl, halogen, OH, or NH2, or 5- or 6-membered heterocycle, optionally substituted with alkyl, halogen, OH, NH2, or a carbonyl, or alkyl, optionally substituted with alkyl, halogen, OH, or NH2, thereby inhibiting the growth of, or killing, the fungus.

### Claim 2 (depends on 1)

The method of claim 1, wherein the potentiator compound potentiates the activity of the antifungal agent.

### Claim 3 (depends on 1)

The method of claim 1, wherein the potentiator compound is not an antifungal compound.

### Claim 4

A method of inhibiting the growth of, or killing, a fungus, the method comprising contacting the fungus with an effective amount of:
(a) an antifungal agent; and
(b) one or more potentiator compounds of Formula Ia:
or pharmaceutically acceptable salts, hydrates, and solvates thereof,
wherein each R1 is independently —OH, —OC(O)H, —OC(O)alkyl, —NH2, —NH-alkyl, —N(alkyl)2, —NH-aminoacid, —NHC(O)alkyl, —NHC(O)aryl, —NH(S(O)2)alkyl,
wherein the alkyl is optionally substituted, —NH(S(O)2)aryl,
wherein the aryl is optionally substituted, or a five-membered heteroaryl, optionally substituted with alkyl, halogen, OH, or NH2, or 5- or 6-membered heterocycle, optionally substituted with alkyl, halogen, OH, NH2, or a carbonyl, or alkyl, optionally substituted with alkyl, halogen, OH, or NH2,
thereby inhibiting the growth of, or killing, the fungus.

### Claim 5 (depends on 4)

The method of claim 4, wherein the compound is

### Claim 6 (depends on 4)

The method of claim 4, wherein the compound is

### Claim 7 (depends on 4)

The method of claim 4, wherein the compound is

### Claim 8 (depends on 4)

The method of claim 4, wherein the compound is

### Claim 9 (depends on 4)

The method of claim 4, wherein the potentiator compound enhances the activity of the antifungal agent.

### Claim 10 (depends on 4)

The method of claim 4, wherein the potentiator compound is not an antifungal compound.

### Claim 11

A method of inhibiting the growth of, or killing, a fungus, the method comprising contacting the fungus with:
(a) an antifungal agent; and
(b) one or more potentiator compounds of Formula Ib:
or pharmaceutically acceptable salts, hydrates, and solvates thereof,
wherein each R1 is independently —OH, —OC(O)H, —OC(O)alkyl, —NH2, —NH-alkyl, —N(alkyl)2, —NH-aminoacid, —NHC(O)alkyl, —NHC(O)aryl, —NH(S(O)2)alkyl,
wherein the alkyl is optionally substituted, —NH(S(O)2)aryl,
wherein the aryl is optionally substituted, or a five-membered heteroaryl, optionally substituted with alkyl, halogen, OH, or NH2, or 5- or 6-membered heterocycle, optionally substituted with alkyl, halogen, OH, NH2, or a carbonyl, or alkyl, optionally substituted with alkyl, halogen, OH, or NH2.
thereby inhibiting the growth of, or killing, the fungus.

### Claim 12 (depends on 11)

The method of claim 11, wherein the compound is

### Claim 13 (depends on 11)

The method of claim 11, wherein the compound is

### Claim 14 (depends on 11)

The method of claim 11, wherein the potentiator compound potentiates the activity of the antifungal agent.

### Claim 15 (depends on 11)

The method of claim 11, wherein the potentiator compound is not an antifungal compound.

### Claim 16

A method of treating a fungal infection in a subject in need thereof, the method comprising administering to the subject an effective amount of:
(a) an antifungal agent; in combination with
(b) an effective amount of one or more potentiator compounds of Formula I:
or pharmaceutically acceptable salts, hydrates, and solvates hereof,
wherein each R1 is independently —OH, —OC(O)H, —OC(O)alkyl, —NH2, —NH-alkyl, —N(alkyl)2, —NH-aminoacid, —NHC(O)alkyl, —NHC(O)aryl, —NH(S(O)2)alkyl, wherein the alkyl is optionally substituted, —NH(S(O)2)aryl,
wherein the aryl is optionally substituted, or a five-membered heteroaryl, optionally substituted with alkyl, halogen, OH, or NH2, or 5- or 6-membered heterocycle, optionally substituted with alkyl, halogen, OH, NH2, or a carbonyl, or alkyl, optionally substituted with alkyl, halogen, OH, or NH2,
thereby treating the fungal infection.

### Claim 17 (depends on 16)

The method of claim 16, wherein the potentiator compound potentiates the activity of the antifungal agent.

### Claim 18 (depends on 16)

The method of claim 16, wherein the potentiator compound is not an antifungal compound.

### Claim 19

A method of treating a fungal infection in a subject in need thereof, the method comprising administering to the subject an effective amount of
(a) an antifungal agent; in combination with
(b) an effective amount of one or more potentiator compounds of Formula Ia:
or pharmaceutically acceptable salts, hydrates, and solvates thereof,
wherein each R1 is independently —OH, —OC(O)H, —OC(O)alkyl, —NH2, —NH-alkyl, —N(alkyl)2, —NH-aminoacid, —NHC(O)alkyl, —NHC(O)aryl, —NH(S(O)2)alkyl,
wherein the alkyl is optionally substituted, —NH(S(O)2)aryl,
wherein the aryl is optionally substituted, or a five-membered heteroaryl, optionally substituted with alkyl, halogen, OH, or NH2, or 5- or 6-membered heterocycle, optionally substituted with alkyl, halogen, OH, NH2, or a carbonyl, or alkyl, optionally substituted with alkyl, halogen, OH, or NH2,
thereby treating the fungal infection.

### Claim 20 (depends on 19)

The method of claim 19, wherein the compound is

### Claim 21 (depends on 19)

The method of claim 19, wherein the compound is

### Claim 22 (depends on 19)

The method of claim 19, wherein the compound is

### Claim 23 (depends on 19)

The method of claim 19, wherein the compound is

### Claim 24 (depends on 19)

The method of claim 19, wherein the potentiator compound potentiates the activity of the antifungal agent.

### Claim 25 (depends on 19)

The method of claim 19, wherein the potentiator compound is not an antifungal compound.

### Claim 26

A method of treating a fungal infection in a subject in need thereof, the method comprising administering to the subject an effective amount of:
(a) an antifungal agent; in combination with
(b) an effective amount of one or more potentiator compounds of Formula Ib:
or pharmaceutically acceptable salts, hydrates, and solvates thereof,
wherein each R1 is independently —OH, —OC(O)H, —OC(O)alkyl, —NH2, —NH-alkyl, —N(alkyl)2, —NH-aminoacid, —NHC(O)alkyl, —NHC(O)aryl, —NH(S(O)2)alkyl,
wherein the alkyl is optionally substituted, —NH(S(O)2)aryl,
wherein the aryl is optionally substituted, or a five-membered heteroaryl, optionally substituted with alkyl, halogen, OH, or NH2, or 5- or 6-membered heterocycle, optionally substituted with alkyl, halogen, OH, NH2, or a carbonyl, or alkyl, optionally substituted with alkyl, halogen, OH, or NH2,
thereby treating the fungal infection.

### Claim 27 (depends on 26)

The method of claim 26, wherein the potentiator compound enhances the activity of the antifungal agent.

### Claim 28 (depends on 26)

The method of claim 26, wherein the potentiator compound is not an antifungal compound.

### Claim 29

A method of treating or preventing relapsing vaginitis in a subject in need thereof, the method comprising administering to the subject an effective amount of:
(a) miconazole, in combination with,
(b) an effective amount of potentiator Compound 1:
thereby treating the relapsing vaginitis in the subject.

### Claim 30

A method of treating or preventing oral candidiasis in a subject in need thereof, the method comprising administering to the subject an effective amount of
(a) miconazole; in combination with,
(b) an effective amount of potentiator Compound 1:
thereby treating the oral candidiasis in the subject.

### Claim 31

A method of treating a fungal infection of a medical device, the method comprising administering to the device an effective amount of:
(a) miconazole, in combination with,
(b) an effective amount of potentiator Compound 1:
thereby treating the fungal infection.

### Claim 32

A method of inhibiting the growth of, or killing, a fungus, the method comprising contacting the fungus with:
thereby inhibiting the growth of, or killing, the fungus.

### Claim 33

A method of treating a fungal infection in a subject in need thereof, the method comprising administering to the subject an effective amount of:
thereby treating the fungal infection.

### Claim 34

A method of treating or preventing relapsing vaginitis in a subject in need thereof, the method comprising administering to the subject an effective amount of potentiator Compound 1:
thereby treating the relapsing vaginitis in the subject.

### Claim 35

A method of treating or preventing oral candidiasis in a subject in need thereof, the method comprising administering to the subject an effective amount of potentiator Compound 1:
thereby treating the oral candidiasis in the subject.

### Claim 36

A method of treating a fungal infection of a medical device, the method comprising administering to the device an effective amount of potentiator Compound 1:
thereby treating the fungal infection of the device.

### Claim 37

A method of inhibiting the growth of, or killing, a C. albicans fungus, the method comprising contacting the fungus with an effective amount of:
(a) an antifungal agent; and
(b) one or more potentiator compounds of Formula I:
or pharmaceutically acceptable salts, hydrates, and solvates thereof,
wherein each R1 is independently —OH, —OC(O)H, —OC(O)alkyl, —NH2, —NH-alkyl, —N(alkyl)2, —NH-aminoacid, —NHC(O)alkyl, —NHC(O)aryl, —NH(S(O)2)alkyl,
wherein the alkyl is optionally substituted, —NH(S(O)2)aryl,
wherein the aryl is optionally substituted, or a five-membered heteroaryl, optionally substituted with alkyl, halogen, OH, or NH2, or 5- or 6-membered heterocycle, optionally substituted with alkyl, halogen, OH, NH2, or a carbonyl, or alkyl, optionally substituted with alkyl, halogen, OH, or NH2,
thereby inhibiting the growth of, or killing, the fungus.

### Claim 38

A method of inhibiting the growth of, or killing, a C. albicans fungus, the method comprising contacting the fungus with an effective amount of:
(a) an antifungal agent; and
(b) one or more potentiator compounds of Formula Ia:
or pharmaceutically acceptable salts, hydrates, and solvates thereof,
wherein each R1 is independently —OH, —OC(O)H, —OC(O)alkyl, —NH2, —NH-alkyl, —N(alkyl)2, —NH-aminoacid, —NHC(O)alkyl, —NHC(O)aryl, —NH(S(O)2)alkyl, wherein the alkyl is optionally substituted, —NH(S(O)2)aryl,
wherein the aryl is optionally substituted, or a five-membered heteroaryl, optionally substituted with alkyl, halogen. OH, or NH2, or 5- or 6-membered heterocycle, optionally substituted with alkyl, halogen, OH, NH2, or a carbonyl, or alkyl, optionally substituted with alkyl, halogen, OH, or NH2,
thereby inhibiting the growth of, or killing, the fungus.

### Claim 39

A method of inhibiting the growth of or killing, a C. albicans fungus, the method comprising contacting the fungus with:
(a) an antifungal agent; and
(b) one or more potentiator compounds of Formula Ib:
or pharmaceutically acceptable salts, hydrates, and solvates thereof,
wherein each R1 is independently —OH, —OC(O)H, —OC(O)alkyl, —NH2, —NH-alkyl, —N(alkyl)2, —NH-aminoacid, —NHC(O)alkyl, —NHC(O)aryl, —NH(S(O)2)alkyl,
wherein the alkyl is optionally substituted, —NH(S(O)2)aryl,
wherein the aryl is optionally substituted, or a five-membered heteroaryl, optionally substituted with alkyl, halogen, OH, or NH2, or 5- or 6-membered heterocycle, optionally substituted with alkyl, halogen, OH, NH2, or a carbonyl, or alkyl, optionally substituted with alkyl, halogen, OH, or
thereby inhibiting the growth of, or killing, the fungus.

### Claim 40

A method of treating a C. albicans fungal infection in a subject in need thereof, the method comprising administering to the subject an effective amount of:
(a) an antifungal agent; in combination with
(b) an effective amount of one or more potentiator compounds of Formula I:
or pharmaceutically acceptable salts, hydrates, and solvates thereof,
wherein each R1 is independently —OH, —OC(O)H, —OC(O)alkyl, —NH2, —NH-alkyl, —N(alkyl)2, —NH-aminoacid, —NHC(O)alkyl, —NHC(O)aryl, —NH(S(O)2)alkyl, wherein the alkyl is optionally substituted, —NH(S(O)2)aryl,
wherein the aryl is optionally substituted, or a five-membered heteroaryl, optionally substituted with alkyl, halogen, OH, or NH2, or 5- or 6-membered heterocycle, optionally substituted with alkyl, halogen, OH, NH2, or a carbonyl, or alkyl, optionally substituted with alkyl, halogen, OH, or NH2,
thereby treating the fungal infection.

### Claim 41

A method of treating a C. albicans fungal infection in a subject in need thereof, the method comprising administering to the subject an effective amount of:
(a) an antifungal agent; in combination with
(b) an effective amount of one or more potentiator compounds of Formula Ia:
or pharmaceutically acceptable salts, hydrates, and solvates thereof,
wherein each R1 is independently —OH, —OC(O)H, —OC(O)alkyl, —NH2, —NH-alkyl, —N(alkyl)2, —NH-aminoacid, —NHC(O)alkyl, —NHC(O)aryl, —NH(S(O)2)alkyl,
wherein the alkyl is optionally substituted, —NH(S(O)2)aryl,
wherein the aryl is optionally substituted, or a five-membered heteroaryl, optionally substituted with alkyl, halogen, OH, or NH2, or 5- or 6-membered heterocycle, optionally substituted with alkyl, halogen, OH, NH2, or a carbonyl, or alkyl, optionally substituted with alkyl, halogen, OH, or NH2,
thereby treating the fungal infection.

### Claim 42

A method of treating a C. albicans fungal infection in a subject in need thereof, the method comprising administering to the subject an effective amount of:
(a) an antifungal agent; in combination with
(b) an effective amount of one or more potentiator compounds of Formula Ib:
or pharmaceutically acceptable salts, hydrates, and solvates thereof,
wherein each R1 is independently —OH, —OC(O)H, —OC(O)alkyl, —NH2, —NH-alkyl, —N(alkyl)2, —NH-aminoacid, —NHC(O)alkyl, —NHC(O)aryl, —NH(S(O)2)alkyl,
wherein the alkyl is optionally substituted, —NH(S(O)2)aryl,
wherein the aryl is optionally substituted, or a five-membered heteroaryl, optionally substituted with alkyl, halogen. OH, or NH2, or 5- or 6-membered heterocycle, optionally substituted with alkyl, halogen, OH, NH2, or a carbonyl, or alkyl, optionally substituted with alkyl, halogen, OH, or NH2,
thereby treating the fungal infection.
